Results 11 to 20 of about 41,093 (226)

Stereotactic radiotherapy with Gamma Master System® for palliation of hepatocellular carcinoma in patients with liver cirrhosis [PDF]

Radiation Oncology
Background Stereotactic radiotherapy with Gamma Master System® delivered for portal vein tumor thrombosis (PVTT) located in the main portal vein is previously exploited.
Bin Qiu, Fang Fang, Peng Zhen, Junjie Wang   +3 more
doaj   +2 more sources

Radiobiology of stereotactic radiotherapy [PDF]

Reports of Practical Oncology and Radiotherapy, 2022
This paper focuses on the radiobiological mechanisms underlying the effects of stereotactic radiotherapy (SRT ) which, despite SRT expansion, have not yet been fully elucidated. Some authors postulated that radiobiology principles, as applied to conventional fractionations (5R: reoxygenation, repair, repopulation, redistribution, radioresistence ...
Mangoni, Monica, Borghesi, Simona, Aristei, Cynthia, Becherini, Carlotta   +3 more
openaire   +2 more sources

A Case Report of Checkpoint Inhibitor Pneumonitis Caused by PD-1
Antibody-Safety and Effectiveness of Pirfenidone

Chinese Journal of Lung Cancer, 2021
Background and objective Immune checkpoint inhibitor associated pneumonia (CIP) is a serious side effect of immune checkpoint inhibitors. There is a consensus on the treatment of acute phase of CIP, but the treatment of pulmonary interstitial fibrosis ...
Haiming YU, Jinying LI, Lan YU, Xi CHENG, Xiaona HAN, Xiaotao ZHANG   +5 more
doaj   +1 more source

Stereotactic radiosurgery for post operative brain metastasic surgical cavities: a single institution experience

Radiation Oncology, 2022
Background The standard therapy for brain metastasis was surgery combined with whole brain radiotherapy (WBRT). The latter is however, associated with important neurocognitive toxicity.
Marie Cantaloube, Mohamed Boucekine, Anne Balossier, Xavier Muracciole, Mickael Meyer, Christine Delsanti, Romain Carron, Yassine Mohamed Beltaifa, Domnique Figarella-Branger, Jean Regis, Laetitia Padovani   +10 more
doaj   +1 more source

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy

Surgical Neurology International, 2022
Background: Numerous studies have reported about good tumor control with both stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) for residual and recurrent craniopharyngiomas, but no studies have reported on the appropriate use of different types of radiation modalities.
Kamogawa, Misaki, Shuto, Takashi, Matsunaga, Shigeo   +2 more
openaire   +2 more sources

A machine learning approach for differentiating malignant from benign enhancing foci on breast MRI

European Radiology Experimental, 2020
Background Differentiate malignant from benign enhancing foci on breast magnetic resonance imaging (MRI) through radiomic signature. Methods Forty-five enhancing foci in 45 patients were included in this retrospective study, with needle biopsy or imaging
Natascha C. D’Amico, Enzo Grossi, Giovanni Valbusa, Francesca Rigiroli, Bernardo Colombo, Massimo Buscema, Deborah Fazzini, Marco Ali, Ala Malasevschi, Gianpaolo Cornalba, Sergio Papa   +10 more
doaj   +1 more source

Stereotactic Radiotherapy for Oligometastasis [PDF]

Cancers, 2019
Oligometastatic disease is defined as “a condition with a few metastases arising from tumors that have not acquired a potential for widespread metastases.” Its behavior suggests a transitional malignant state somewhere between localized and metastatic cancer.
Sotaro Otake, Taichiro Goto
openaire   +2 more sources

Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report

Journal of Medical Case Reports, 2022
Background Hematomas that slowly increase in size for more than 1 month after the initial hemorrhage are referred to as chronic expanding hematomas. Chronic expanding hematoma can also occur after radiosurgery; however, there have been no reports about ...
Yojiro Ishikawa, Takaya Yamamoto, Rei Umezawa, Noriyoshi Takahashi, Kazuya Takeda, Yu Suzuki, Keiichi Jingu   +6 more
doaj   +1 more source

Prolonged overall treatment time negatively affects the outcomes of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: A propensity score-weighted, single-center analysis.

PLoS ONE, 2021
Previous studies have reported conflicting results for the effect of overall treatment time with stereotactic body radiotherapy on tumor control in early-stage non-small-cell lung cancer.
Toshiki Ikawa, Takahiro Tabuchi, Koji Konishi, Masahiro Morimoto, Takero Hirata, Naoyuki Kanayama, Kentaro Wada, Masayasu Toratani, Sumiyo Okawa, Kazuhiko Ogawa, Teruki Teshima   +10 more
doaj   +1 more source

Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report

Journal of Medical Case Reports, 2017
Background In recent reports, re-irradiation with stereotactic body radiotherapy for lung tumors in patients previously treated with thoracic radiation therapy resulted in several serious toxicities.
Hotaka Nonaka, Hiroshi Onishi, Masatoki Ozaki, Kengo Kuriyama, Takafumi Komiyama, Ryo Saito   +5 more
doaj   +1 more source